Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.

Should you exercise differently if you’re on a GLP-1 weight loss drug such as Ozempic or Wegovy? Here’s what to know about which physical activities best support your health goals.

News Evidence That GLP-1 Drugs Achieve Weight Loss Primarily by Reducing Fat Mass More Than Muscle. Diabetes and obesity have become pressing health issues worldwide. Glucagon-lik ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...

Pancreatic health regulates digestion and blood sugar. Learn to prevent diabetes, pancreatitis, and cancer through diet, ...

Mor than 800 million people worldwide are living with diabetes, according to World Health Organization (WHO) estimates, with numbers steadily increasing.

Quinn Peterson and colleagues from Mayo Clinic, USA, discovered a method for making human alpha cells from cultures of ...

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.